The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
CAR-T Meeting 2020 | Exciting data from the 2nd European CAR T-Cell Meeting
Robin Sanderson, MBChB, MRCP, FRCPath, King’s College Hospital NHS Foundation Trust, London, UK, outlines the updates presented at the 2nd European CAR T-Cell Meeting in Sitges, Spain. Dr Sanderson highlights the ZUMA-1 trial and axicabtagene ciloleucel for mantle cell lymphoma. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.
